Our results revealed that HER2 mRNA is statistically significant in differentiating not only HER2‐ positive from ‐negative BC, but also in the HER2‐low class, where it can separate them into two distinct groups and which are correlated with IHC protein level and gene amplification. The gene discussed is ERBB2; the disease is breast cancer.